CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 200 enrolled
Drug / intervention
Normal Saline containing a prophylactic Antibiotic 1 g +1 moredrug
Likely dose
Normal Saline containing a prophylactic Antibiotic 1 gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02739815
NCT02739815Phase 4Completed
CompareCT.gov

Comparative Study For Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section: A Randomised Controlled Trial

Talkha Central Hospital·interventional·Posted Apr 15, 2016·Updated Jun 15, 2016

In Brief

A Phase 4 clinical trial evaluating Normal Saline containing a prophylactic Antibiotic 1 g and Tranexamic Acid for Hemorrhage of Cesarean Section and/or Perineal Wound and Postpartum Hemorrhage. Completed, enrolled 200 participants across 1 site.

Detailed Summary

This study aims to define a safe prophylactic intravenous TXA dose with an advantage over others in reducing total blood loss volume at secondary uncomplicated LSCS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage of Cesarean Section and/or Perineal Wound, Postpartum Hemorrhage
CountriesEgypt
CollaboratorsAl-Azhar University

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 15, 2016
Enrollment StartApr 1, 2016
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.2 years ago

Interventions

Normal Saline containing a prophylactic Antibiotic 1 gdrug

500 ml of normal saline containing a prophylactic Antibiotic 1 g.

Tranexamic Aciddrug

Tranexamic acid